Welcome Guest! To enable all features please  Log In or Register

ALS Resources


Favorites

Log In or Register to see a list of your favorite topics.
Breakthrough Provides New Tool for Degenerative Di
regina
Posted: Sunday, October 01, 2006 7:40:12 PM
Rank: Newbie

Groups: Member

Joined: 8/6/2004
Posts: 3
Breakthrough Provides New Tool for Degenerative Disease Studies

AScribe Newswire

09-26-06

CORVALLIS, Ore., Sept. 25 (AScribe Newswire) -- Scientists in the Linus Pauling Institute at Oregon State University have discovered a new technique to let them watch, visualize and precisely measure a key oxidant in animal cells, an important breakthrough that could dramatically speed research on everything from Lou Gehrig's Disease to heart disease, hypertension, diabetes and aging.

The findings are being published online this week in Proceedings of the National Academy of Sciences, a professional journal. They could open the door to major advances on some of the world's most significant degenerative diseases, researchers say.

The OSU scientists, in collaboration with Molecular Probes-Invitrogen of Eugene, Ore., found a chemical process to directly see and visualize "superoxide" in actual cells. This oxidant, which was first discovered 80 years ago, plays a key role in both normal biological processes and - when it accumulates to excess - the destruction or death of cells and various disease processes.

"In the past, our techniques for measuring or understanding superoxide were like blindly hitting a box with a hammer and waiting for a reaction," said Joseph Beckman, a professor of biochemistry and director of the OSU Environmental Health Sciences Center. "Now we can really see and measure, in real time, what's going on in a cell as we perform various experiments."

In research on amyotrophic lateral sclerosis, or Lou Gehrig's Disease, which is one of his lab's areas of emphasis, Beckman said they have used the new technique to learn as much in the past three months about the basic cell processes as they did in the previous 15 years. Hundreds of experiments can now rapidly be done that previously would have taken much longer or been impossible.

"This will enable labs all over the world to significantly speed up their work on the basic causes and processes of many diseases, including ALS, arthritis, diabetes, Parkinson's disease, Alzheimer's disease, heart disease and others," Beckman said. "And it should be especially useful in studying aging, particularly the theory that one cause of aging is mitochondrial decay."

The process of oxidation in the body, researchers say, is one that's fundamental to life but also prone to problems. Oxygen in the cells can be reduced to a molecule called superoxide, which is part of normal immune system processes and may also have other functions - it was first named by OSU alumnus Linus Pauling in 1934.

"Oxygen is actually one of the more toxic molecules in the environment," Beckman said. "Breathing 100 percent pure oxygen will destroy your lungs in about three days because it increases the formation of superoxide."

Superoxide is efficiently removed by an enzyme, superoxide dismutase. Antioxidants in food, such as vitamin C and E, are also part of this process. And in healthy animals, including humans, this delicate balancing act can work well and cause few problems. But sometimes the process breaks down and excess levels of superoxide begin to accumulate and lead to a wide variety of degenerative diseases.

Prior to this, there was no direct and accurate way to measure superoxide or its origin from the two places that produce it, the cell's cytosol or mitochondria. Now there is.

With the new system developed at OSU, researchers can use a fluorescent microscope, a fairly standard laboratory tool, to actually see levels of superoxide and observe changes as experiments are performed with living cells.

"If we poison the mitochondria, using something like the pesticides that have been implicated in Parkinson's disease, we can actually see superoxide levels begin to rapidly rise," Beckman said. "You get a similar reaction if a growth factor is added that's implicated in the development of Lou Gehrig's Disease."

The data available from this new technology, Beckman said, are so profound that for some time many in the science community didn't believe it was possible.

"This will become a critical tool in learning how superoxide works in a cell," he said. "I've been studying this for more than 10 years and never thought we would have such a clear and accurate picture of what's going on inside a living cell."

In their research on ALS, for instance, OSU scientists have used the new system to actually see cells eating themselves alive and dying from excess superoxide production. A new compound is in phase one clinical trials that appears to inhibit this process and may ultimately provide a therapy for the disease.

Oxidative stress resulting from mitochondrial dysfunction has already been implicated in neurodegeneration, aging, diabetes and cancer, the researchers said in their report. The new findings could rapidly speed research in all of those fields, they said.

This research was funded by grants from the National Institutes of Health and the OSU Environmental Health Sciences Center.

- - - -

CONTACTS:

David Stauth, OSU News, 541-737-0787

Source: Joseph Beckman, 541-737-8867

Questioner
Posted: Sunday, October 01, 2006 11:50:18 PM
Rank: Advanced Member

Groups: Member

Joined: 4/11/2006
Posts: 623
Quote:
quote:Originally posted by regina
Breakthrough Provides New Tool for Degenerative Disease Studies

AScribe Newswire

09-26-06

CORVALLIS, Ore., Sept. 25 (AScribe Newswire) --

In research on amyotrophic lateral sclerosis, or Lou Gehrig's Disease, which is one of his lab's areas of emphasis, Beckman said they have used the new technique to learn as much in the past three months about the basic cell processes as they did in the previous 15 years. Hundreds of experiments can now rapidly be done that previously would have taken much longer or been impossible.



This sounds pretty impressive; should we be as impressed as this statement suggests we be? Seems more hopeful than blindly throwing darts, i.e. trials using this or that, without even knowing what the target is.
RAB
Posted: Monday, October 02, 2006 2:23:08 AM
Rank: Newbie

Groups: Member

Joined: 8/25/2006
Posts: 18
Location: USA
Two questions based on the following excerpts.

1. What growth factor is implicated in ALS?

2. Which phase I are they refering to?

<u>"You get a similar reaction if a growth factor is added that's implicated in the development of Lou Gehrig's Disease."

"A new compound is in phase one clinical trials that appears to inhibit this process and may ultimately provide a therapy for the disease. "</u>
Jeff Schaffer
Posted: Monday, October 02, 2006 1:27:39 PM
Rank: Advanced Member

Groups: Member

Joined: 3/26/2006
Posts: 2,135
Location: USA
Dr. McCarty..Is this not a hell of a find?? If you can see the cell being destroyed, can you not see whats doing the destroying?? Will this also let you see the neurons and whats happening to them?? Sounds to simple to me..Thoughts please ?/ Ron
jmccarty
Posted: Tuesday, October 03, 2006 4:39:17 PM

Rank: Advanced Member

Groups: Administration , Member

Joined: 1/15/2009
Posts: 2,276
Location: Cambridge , MA
Thoughts and Answers:

I tried calling Dr. Beckman and get the word from the horse’s mouth – I couldn’t reach him yet so I’ll take some guesses. The factor being referred to is presumably NGF – Nerve Growth Factor. Dr. Beckman has focused a fair amount of research on this protein which certainly has the potential to be relevant for ALS:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16524372&query_hl=27&itool=pubmed_docsum

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17004921&query_hl=27&itool=pubmed_docsum

I’m going to guess that the Phase one drug would be Aeolus 10150 – the synthetic antioxidant that recently completed a Phase 1 trial.

This work is certainly of value to researchers, including those looking at ALS. However, the importance would be potentially depending on one’s own research interests and for how critical oxidation as a causation and progressive mechanism. There are those who would argue, especially in the progression arena, that oxidation defects (such as arising from altered SOD activities) are secondary to issues arising from misfolded protein more generally. I would tend more toward this opinion given the current trends and state of knowledge.


John McCarty, PhD
Treatment Investigator,
ALS Therapy Development Foundation

John McCarty, PhD
Director of Therapeutic Investigation
ALS Therapy Development Institute
Jeff Schaffer
Posted: Tuesday, October 03, 2006 5:04:37 PM
Rank: Advanced Member

Groups: Member

Joined: 3/26/2006
Posts: 2,135
Location: USA
Doc, could the technic be used to view whats happening to neurons as they are being destroyed? Or mitochondria?? This sounds like to good a tool to not use in the search to look at whats happening in ALS.. It might let you see whats killing the neurons. Please explain why you dont see a use in your lab..Ron
jmccarty
Posted: Tuesday, October 03, 2006 5:11:28 PM

Rank: Advanced Member

Groups: Administration , Member

Joined: 1/15/2009
Posts: 2,276
Location: Cambridge , MA
Ron, we would use any technology that’s necessary – perhaps even this. Currently, however, we would be pursuing different hypothesis on the disease mechanism. An example would be to focus more on how misfolded proteins might be clogging the pipe (the axonal connections between the neural bodies and other neurons or the muscles).

John McCarty, PhD
Treatment Investigator,
ALS Therapy Development Foundation

John McCarty, PhD
Director of Therapeutic Investigation
ALS Therapy Development Institute
Jeff Schaffer
Posted: Wednesday, October 04, 2006 8:16:53 AM
Rank: Advanced Member

Groups: Member

Joined: 3/26/2006
Posts: 2,135
Location: USA
My question is ,cant you use the scope and light they are using to see the neurons, fold , unfold..Other wise, view the als mechanism as it destroys the neurons, cells?? Ron
Quote:
quote:Originally posted by jmccarty
Ron, we would use any technology that’s necessary – perhaps even this. Currently, however, we would be pursuing different hypothesis on the disease mechanism. An example would be to focus more on how misfolded proteins might be clogging the pipe (the axonal connections between the neural bodies and other neurons or the muscles).

John McCarty, PhD
Treatment Investigator,
ALS Therapy Development Foundation
jmccarty
Posted: Wednesday, October 04, 2006 8:26:11 AM

Rank: Advanced Member

Groups: Administration , Member

Joined: 1/15/2009
Posts: 2,276
Location: Cambridge , MA
Hi Ron,
The specific technology in the press release is a chemical way to follow and monitor the oxidative state in the cell over time. Thus, it is relatively specific to potential oxidative mechanisms in ALS. More generally, one can certainly monitor the axons and junctions with the muscle with microscopy. TDF just spent a significant chunk of change in acquiring the state-of-the-art ‘scopes that will allow us to do that in projects that are integrated with the programs in drug testing and understanding of fundamental biology of ALS. Relatively limited research has been done along these lines to date.


John McCarty, PhD
Treatment Investigator,
ALS Therapy Development Foundation

John McCarty, PhD
Director of Therapeutic Investigation
ALS Therapy Development Institute
Jeff Schaffer
Posted: Wednesday, October 04, 2006 9:23:28 AM
Rank: Advanced Member

Groups: Member

Joined: 3/26/2006
Posts: 2,135
Location: USA
Thanks Dr. McCarty..I thought they might have been on to something to help find the cause. Why do they even bother Its like'' well we better post something or they might cut off $$ '' This is getting tiresome..Ron
jmccarty
Posted: Wednesday, October 04, 2006 9:29:41 AM

Rank: Advanced Member

Groups: Administration , Member

Joined: 1/15/2009
Posts: 2,276
Location: Cambridge , MA
Ron,
Keep in mind that researcher do what they do and marketing people do what they do. Press releases are pretty much solely the métier of marketing. The technology developed was probably at a bargain price (and apparently supported by the major company that markets such research tools). I think there is little doubt that it is a valuable research tool – the impact on ALS is less certain but I am sure it will help as researchers paint the overall picture. Currently, my opinion is that this emphasis is the wrong tree to bark up and that the breakthroughs will come in different areas.


John McCarty, PhD
Treatment Investigator,
ALS Therapy Development Foundation

John McCarty, PhD
Director of Therapeutic Investigation
ALS Therapy Development Institute
Users browsing this topic Guest

Forum Jump
You cannot post new topics in this forum.
You cannot reply to topics in this forum.
You cannot delete your posts in this forum.
You cannot edit your posts in this forum.
You cannot create polls in this forum.
You cannot vote in polls in this forum.


Powered By Yet Another Forum
This page was generated in 0.741 seconds.